My site

 Future-forward transformation unifies portfolios, drives growth and boosts customer experience with the power of AI

(BUSINESS WIRE) -- Lyse, one of Norway's largest energy and telecommunication companies, is a pioneer in customer-focused innovation. To wow customers and deliver effortless experiences for generations to come, Lyse chose CSG& ... Read more »

System Designed For Work

SYDNEY - Thursday, 08. August 2024

(BUSINESS WIRE) -- Canva, the world’s largest visual communication platform, today launched a refreshed brand system purpose-built for workplaces worldwide. The updated identity was designed to scale globally and connect locally, doubling down on Canva’s mission to empower the world to design.

Empowering Canva’s Next Decade

Canva’s first decade empowered millions of individuals to achieve their goals through design. Now, it’s focussed on empowering organisations too, with design and productivity tools to support the growing visual communication needs of every workplace in every part of the world. 

As the world of work becomes more distributed, the need for stronger visual communication and collaboration has never been more paramount. Canva’s refreshed brand system is built to not only fuel creativity but also to help teams ... Read more »

 Partnership extends access in Asia to Parse’s growing single cell portfolio

(BUSINESS WIRE) -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific.

“Biotech, phar ... Read more »

 Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its interim results for the six months ended 30 June 2024.

(BUSINESS WIRE)--Nichi BRITE Beta glucan administration resulted in enhancement of immunity followed by reduction in biomarkers of pancreatic cancer and that of its recurrence in patients undergoing surgical resection of malignant pancreatic tumor, which was presented at the ASCO® Breakthrough meeting in Yokohama, Japan. IgA and CD209, markers of immunity enhanced while CA19-9, the marker of pancreatic cancer and CD44, that of cancer recurrence and severity, significantly reduced in patients who had Nichi BRITE, compared to the control group in the study by gastro-enterology surgeons and nutritional support team of Chikamori Hospital, Kochi, Japan. Importantly, the mean survival improved after Nichi BRITE administration.

Pancreatic cancer has a very poor prognosis. Earlier data of Nichi BRITE allergen-free food supplement on safety and efficacy in improving the immune system, decreasing tumor size in animal models and improving NK cell cytotoxicity in healthy volunteers, ... Read more »